Diallyllysergamide

Diallyllysergamide
Clinical data
Other namesDAL, Lysergic acid diallylamide, d-lysergic acid diallylamide, d-diallyllysergamide
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
Pharmacokinetic data
Metabolismhepatic
Excretionrenal
Identifiers
  • (6aR,9R)-N,N-Diallyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
ECHA InfoCard100.163.206
Chemical and physical data
FormulaC22H25N3O
Molar mass347.462 g·mol−1
3D model (JSmol)
  • C=CCN(CC=C)C(=O)[C@@H]2C=C1c3cccc4[nH]cc(C[C@H]1N(C)C2)c34
  • InChI=1S/C22H25N3O/c1-4-9-25(10-5-2)22(26)16-11-18-17-7-6-8-19-21(17)15(13-23-19)12-20(18)24(3)14-16/h4-8,11,13,16,20,23H,1-2,9-10,12,14H2,3H3/t16-,20-/m1/s1 Y
  • Key:VAMQYGHNZLRSSA-OXQOHEQNSA-N Y
  (verify)

N,N-Diallyllysergamide (DAL, as the tartrate salt), also known as lysergic acid diallylamide, is a psychedelic lysergamide related to lysergic acid diethylamide (LSD). In their book TiHKAL, Alexander and Ann Shulgin describe it as being "an order of magnitude less potent than LSD itself".

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.